Teleflex Inc
TFX122.240USD
-0.050-0.04%
Handelsschluss 12/24, 16:00（ET）Kurse um 15 Minuten verzögert
5.40BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Teleflex Inc Unternehmen
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Teleflex Inc Informationen
BörsenkürzelTFX
Name des UnternehmensTeleflex Inc
IPO-datumMar 17, 1980
CEOKelly (Liam J)
Anzahl der mitarbeiter14100
WertpapierartOrdinary Share
GeschäftsjahresendeMar 17
Addresse550 E Swedesford Rd
StadtWAYNE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19087
Telefon16102256800
Websitehttps://www.teleflex.com/usa/en/#
BörsenkürzelTFX
IPO-datumMar 17, 1980
CEOKelly (Liam J)
Führungskräfte von Teleflex Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
3.08K
+95.06%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
Andere
136.24M
17.45%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
525.64M
67.31%
EMEA
166.23M
21.29%
Asia Pacific
89.03M
11.40%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
Andere
136.24M
17.45%
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Andere
53.03%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Andere
53.03%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
57.71%
Investment Advisor/Hedge Fund
36.75%
Hedge Fund
9.11%
Pension Fund
1.76%
Sovereign Wealth Fund
1.36%
Research Firm
0.92%
Bank and Trust
0.57%
Family Office
0.37%
Individual Investor
0.34%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
1153
47.10M
106.58%
-5.30M
2025Q2
1158
48.67M
110.13%
-386.02K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
4.97M
11.25%
-385.28K
-7.19%
Jun 30, 2025
The Vanguard Group, Inc.
4.80M
10.86%
-269.49K
-5.32%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
5.94M
13.45%
-272.00K
-4.38%
Jun 30, 2025
Janus Henderson Investors
4.15M
9.39%
-176.31K
-4.08%
Jun 30, 2025
AQR Capital Management, LLC
409.32K
0.93%
+116.80K
+39.93%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
2.40M
5.44%
-373.80K
-13.46%
Jun 30, 2025
State Street Investment Management (US)
1.46M
3.3%
-69.05K
-4.52%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.24M
2.81%
+373.94K
+43.09%
Jun 30, 2025
Cooke & Bieler, L.P.
1.21M
2.73%
+148.44K
+14.04%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco S&P SmallCap Health Care ETF
3.37%
First Trust Indxx Medical Devices ETF
2.09%
First Trust Health Care Alphadex Fund
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.7%
Zacks Small/Mid Cap ETF
0.85%
State Street SPDR S&P 600 Small Cap Value ETF
0.75%
iShares S&P Small-Cap 600 Value ETF
0.75%
Distillate Small/Mid Cash Flow ETF
0.7%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.67%
Mehr Anzeigen
Invesco S&P SmallCap Health Care ETF
Anteil3.37%
First Trust Indxx Medical Devices ETF
Anteil2.09%
First Trust Health Care Alphadex Fund
Anteil1.77%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.7%
Zacks Small/Mid Cap ETF
Anteil0.85%
State Street SPDR S&P 600 Small Cap Value ETF
Anteil0.75%
iShares S&P Small-Cap 600 Value ETF
Anteil0.75%
Distillate Small/Mid Cash Flow ETF
Anteil0.7%
VictoryShares Small Cap Free Cash Flow ETF
Anteil0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Anteil0.67%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
318.10M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 06, 2025
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 15, 2025
Nov 14, 2025
Jul 31, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 15, 2025
Aug 15, 2025
May 12, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 16, 2025 going ex on May 20, 2025
May 20, 2025
Jun 16, 2025
May 20, 2025
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Teleflex Inc?
Die fünf größten Anteilseigner von Teleflex Inc sind:
BlackRock Institutional Trust Company, N.A. hält 4.97M Aktien, was 11.25% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 4.80M Aktien, was 10.86% der Gesamtaktien entspricht.
T. Rowe Price Investment Management, Inc. hält 5.94M Aktien, was 13.45% der Gesamtaktien entspricht.
Janus Henderson Investors hält 4.15M Aktien, was 9.39% der Gesamtaktien entspricht.
AQR Capital Management, LLC hält 409.32K Aktien, was 0.93% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 4.97M Aktien, was 11.25% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 4.80M Aktien, was 10.86% der Gesamtaktien entspricht.
T. Rowe Price Investment Management, Inc. hält 5.94M Aktien, was 13.45% der Gesamtaktien entspricht.
Janus Henderson Investors hält 4.15M Aktien, was 9.39% der Gesamtaktien entspricht.
AQR Capital Management, LLC hält 409.32K Aktien, was 0.93% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Teleflex Inc?
Die drei wichtigsten Anteilseigner-Typen von Teleflex Inc sind:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
Wie viele Institutionen halten Anteile an Teleflex Inc (TFX)?
Mit Stand vom 2025Q3 halten 1153 Institutionen Anteile an Teleflex Inc, mit einem Gesamtmarktwert von etwa 47.10M, was 106.58% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -3.56% gestiegen.
Was ist die größte Einnahmequelle von Teleflex Inc?
Am FY2025Q2 erzielte das Geschäft mit Vascular access für Teleflex Inc den höchsten Umsatz in Höhe von 185.53M, was 23.76% des Gesamtumsatzes entspricht.
